1. Top news from MedWatch this week (21/01)
2. Hearing firms urge FDA to increase OTC safety requirements (21/01)
3. Danish bank cuts Genmab price target, retains "buy" recommendation (21/01)
4. Audientes ships first hearing aid batch to India (21/01)
5. Coloplast initiates trial of ostomy leakage product (21/01)
6. Novo Nordisk launches oral semaglutide in India (21/01)
7. Zealand Pharma finds all patients for phase III study (20/01)
8. Leo Pharma's Boston boss exits company (20/01)
9. Danish bank expects slow start to 2022 for Coloplast, lowers price target (20/01)
10. Swedish bank slashes Novo Nordisk price target ahead of 2022 outlook (20/01)
11. Overwhelming majority passes new EMA powers (20/01)
12. Hearing aid industry association responds to FDA's proposed OTC regulation (20/01)
13. Leo Pharma ends Boston bet (20/01)
14. WSA merges with its independent retailer (20/01)
15. Layoffs and restructuring will prepare Leo Pharma for IPO (19/01)

• NORDIC Medical Sales Director
• Commercial Excellence Lead
• Senior Scientist
• Senior Director, Global Regulatory Lead
• QA Manager GMP/GDP Compliance & Audits
• QA Specialist
• QA Specialist, GMP QA
• Lead Scientist, Global STA, Royal DSM/Glycom
• Principal Scientist
• Health Economist
• GxP QA Compliance Manager for Quality Assurance
• Senior Manager, Biostatistics
• Senior Associate, CMC Pharmaceutical Development
• Medical Director, Translational Medicine
• Design Control Specialist / System Engineer
• Head of Biology Group Human Milk Oligosaccharides & Early Life Nutrition, DSM/Glycom
• Senior Manager, Accounting Operations
• Associate Director, International Medical Affairs
• Senior Quality Assurance Consultant, Denmark
• Clinical Research Associate
• Senior Key Account Manager
• Senior HR Director, HR Denmark, Ferring
• Compound Development Team Lead
• Chemists are wanted for ALK's internal Aircraft Corps
• Director Regulatory Affairs

See all jobs